Patent · US Active

Composition and method for treating congenital cytomegalovirus induced hearing loss

US10238599B2 · kind B2 · utility

1Cited by

21References

24Claims

0Family size

Assignee

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · US

Inventors

Josef Miller · Ann Arbor, US
Glenn E. Green · Dexter, US
Barry S. Seifer · Ann Arbor, US
Albert Park · Salt Lake City, US
Ali Ahmed Almishaal · Dhahran, SA
Phayvanh Phithaksounthone Sjogren · Salt Lake City, US

Key dates

Filing date	Sep 25, 2017
Grant date	Mar 26, 2019
Priority date	—
Expiry date	Sep 25, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2300/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating congenital cytomegalovirus (cCMV) induced hearing loss includes the step administering a composition to the mammal, wherein the composition consists essentially of a biologically effective amount of vitamin A, vitamin E, vitamin C, a vasodilator comprising magnesium, and, optionally, a withanolide, and/or resveratrol.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.